Saturday, June 02, 2012
EXCESS BLUE LIGHT EXPOSURE MAY BE A RISK FACTOR FOR MACULAR DEGENERATION
As blue light-induced damage accumulates over a lifetime, by the time you are in your 40s and 50s, you are at an increased risk for AMD, vision impairment, and decreased visual performance. This article in the Milwaukee Journal Sentinel explains possible protective measures you can take. There is a lot of blue light entering the eye from the sky here in Arizona, so wear your sunglasses!
Thursday, May 31, 2012
DONATING BLOOD LOWERS HEART RISK FOR THOSE WITH OBESITY
Healthday
An interesting finding from this study is that after three weeks of donating blood, those with obesity lowered their systolic blood pressure from 148mmHg to 130mmHg.
An interesting finding from this study is that after three weeks of donating blood, those with obesity lowered their systolic blood pressure from 148mmHg to 130mmHg.
Tuesday, May 22, 2012
ORAL MINOCYCLINE MAY BE USED TO TREAT DIABETIC MACULAR EDEMA
http://www.iovs.org/content/early/2012/05/11/iovs.11-9413.abstract
Conclusions: In this pilot proof-of-concept study of DME, minocycline as primarytreatment was associated with improved visual function, central macular edema and vascular leakage, comparing favorably with historical controls from previous studies. Microglial inhibition with oral minocycline may be a promising therapeutic strategy targeting the inflammatory etiology of DME.
Conclusions: In this pilot proof-of-concept study of DME, minocycline as primarytreatment was associated with improved visual function, central macular edema and vascular leakage, comparing favorably with historical controls from previous studies. Microglial inhibition with oral minocycline may be a promising therapeutic strategy targeting the inflammatory etiology of DME.
Friday, May 18, 2012
Ophthalmology News Article | Smoking and Risk of Age-related Cataract: A Meta-analysis |4076465
Ophthalmology News Article | Smoking and Risk of Age-related Cataract: A Meta-analysis |4076465
This study shows that smoking increases the risk for nuclear cataract.
This study shows that smoking increases the risk for nuclear cataract.
Wednesday, October 12, 2011
STEM CELL TREATMENT FOR MACULAR DEGENERATION
Stem-Cell Clinical Trials Move Debate Beyond Labs - WSJ.com
This is very exciting because to date, there has been no definitive treatment for dry macular degeneration. Studies on rats have demonstrated treatment success for AMD using stem cells, but studies have not yet been done on humans.
Wednesday, October 05, 2011
Daily aspirin tied to risk of vision loss:study | Reuters
Daily aspirin tied to risk of vision loss:study | Reuters
Seniors who take aspirin daily are twice as likely to have late stage macular degeneration, an age-related loss of vision, than people who never take the pain reliever, according to a European study.
Treatment for Pink Eye
Pinkeye Treatment May Be on the Horizon
In the past, it has been thought that there is no treatment for pink eye. This article introduces a possible eye drop treatment to stop pink eye in it's tracks may be developed.
Friday, September 30, 2011
Xanthelasmata Identified as Independent CV Risk Factor - Forbes
Xanthelasmata Identified as Independent CV Risk Factor - Forbes
"The authors conclude that the presence of xanthelasmata could help clinicians when they diagnose heart disease and associated conditions. And they add that their findings “could be of particular value in societies where access to laboratory facilities and thus lipid profile measurement is difficult.”
An accompanying editorial concludes that, overall, the evidence highlights the importance of a comprehensive physical examination and suggests that xanthelasmata could be used by general clinicians to help identify people at higher risk of cardiovascular disease."
Tuesday, September 13, 2011
VITAMIN D MAY NOT BE CRUCIAL IN MACULAR DEGENERATION TREATMENT
Access : Reconsidering the connection between vitamin D levels and age-related macular degeneration : Eye
According to this study there is no correlation between vitamin D levels and macular degeneration progression.
ANTIOXIDANTS MAY HELP IN DIABETIC RETINOPATHY
European Journal of Ophthalmology
Oral antioxidant supplementation could be a useful adjunctive long-term therapy in the treatment of nonproliferative DR.
Friday, September 09, 2011
VIDEO GAMES MAY IMPROVE VISUAL ACUITY IN AMBLYOPIA
Most eye doctors believe amblyopia can't be improved past 11 years old. This study suggests that 40 hours of video game play with the good eye patched will improve visual acuity 30% in patients with ambloypia who are older than 11 years old.
Wednesday, March 30, 2011
Subscribe to:
Posts (Atom)